Insulin aspart and insulin aspart protamine and Ranibizumab Intraocular
Determining the interaction of Insulin aspart and insulin aspart protamine and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin Aspart Protamine and Insulin Aspart
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart and insulin aspart protamine-Ranibizumab ophthalmic
- Insulin aspart and insulin aspart protamine-Ranitidine
- Insulin aspart and insulin aspart protamine-Ranitidine Capsule
- Insulin aspart and insulin aspart protamine-Ranitidine Hydrochloride
- Insulin aspart and insulin aspart protamine-Ranitidine Injection
- Insulin aspart and insulin aspart protamine-Ranitidine Suspension
- Ranibizumab Intraocular-Insulin aspart and insulin degludec Subcutaneous
- Ranibizumab Intraocular-Insulin Aspart Injection
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart
- Ranibizumab Intraocular-Insulin aspart protamine and insulin aspart Subcutaneous
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart (Vials)